Biofilm-Induced Antibiotic Resistance in Clinical Acinetobacter baumannii Isolates
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
In order to understand the role of biofilm in the emergence of antibiotic resistance, a total of 104 clinical Acinetobacter baumannii strains were investigated for their biofilm-forming capacities and genes associated with biofilm formation. Selected biofilm-formers were tested for antibiotic susceptibilities when grown in biofilm phase. Reversibility of antibiotic susceptibility in planktonic cells regrown from biofilm were investigated. We found 59.6% of the strains were biofilm-formers, among which, 66.1% were non-multidrug resistant (MDR) strains. Presence of virulence genes bap, csuE, and abaI was significantly associated with biofilm-forming capacities. When strains were grown in biofilm state, the minimum biofilm eradication concentrations were 44, 407, and 364 times higher than the minimum bactericidal concentrations (MBC) for colistin, ciprofloxacin, and imipenem, respectively. Persisters were detected after treating the biofilm at 32–256 times the MBC of planktonic cells. Reversibility test for antibiotic susceptibility showed that biofilm formation induced reversible antibiotic tolerance in the non-MDR strains but a higher level of irreversible resistance in the extensively drug-resistant (XDR) strain. In summary, we showed that the non-MDR strains were strong biofilm-formers. Presence of persisters in biofilm contributed to the reduced antibiotic susceptibilities. Biofilm-grown Acinetobacter baumannii has induced antibiotic tolerance in non-MDR strains and increased resistance levels in XDR strains. To address the regulatory mechanisms of biofilm-specific resistance, thorough investigations at genome and transcription levels are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Biofilm-forming bacteria, including Staphylococcus aureus, Coagulase-negative staphylococci (CoNS), Pseudomonas aeruginosa, and Acinetobacter baumannii, exhibit resistance to antibiotics that can be as much as 1000 times greater than that of their planktonic counterparts [11,12,13].”
From Biofilm Resilience: Molecular Mechanisms Driving Antibiotic Resistance in Clinical Contexts (2025) · cites this paper as [12]
In the citing paper
“Studies have demonstrated the link between biofilm formation and the rise in antibiotic resistance in microbial cells.”
From Biofilm Resilience: Molecular Mechanisms Driving Antibiotic Resistance in Clinical Contexts (2025) · cites this paper as [12]
In the citing paper
“The regulation of biofilm production is governed by particular genes that influence the expression of antibiotic resistance, underscoring the genetic foundation of this occurrence [12].”
From Biofilm Resilience: Molecular Mechanisms Driving Antibiotic Resistance in Clinical Contexts (2025) · cites this paper as [12]
In the citing paper
“The association of these cells with mechanisms like the suppression of protein translation, induction of dormancy, and development of antibiotic tolerance highlights their role in surviving amid antimicrobial agents [12].”
From Biofilm Resilience: Molecular Mechanisms Driving Antibiotic Resistance in Clinical Contexts (2025) · cites this paper as [12]
In the citing paper
“Persister cells have been observed in a diverse array of bacterial and fungal species, such as P. aeruginosa, E. coli, S. aureus, C. albicans, A. baumannii, and B. cereus [12,157,158,159,160].”
From Biofilm Resilience: Molecular Mechanisms Driving Antibiotic Resistance in Clinical Contexts (2025) · cites this paper as [12]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644 · cited 1×
“baumannii to form biofilm facilitates its survival and persistence in the hospital environments [8,9], this in turn contributes to the extensive spread of this pathogen across the globe [10].”
BackgroundCeri, H., Olson, M. E., Stremick, C., Read, R. R., Morck, D., & Buret, A. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.6.1771-1776.1999 · Cited by 2,155
Research works printed but not linked: 31
- Fournier, 2006, The epidemiology and control of Acinetobacter baumannii in health care facilities, Clin. Infect. Dis., 42, 692, 10.1086/500202 · DOI · Paper page
- Piperaki, 2019, Carbapenem-resistant Acinetobacter baumannii: In pursuit of an effective treatment, Clin. Microbiol. Infect., 25, 951, 10.1016/j.cmi.2019.03.014 · DOI · Paper page
- Niu, 2020, Wza gene knockout decreases Acinetobacter baumannii virulence and affects wzy-dependent capsular polysaccharide synthesis, Virulence, 11, 1, 10.1080/21505594.2019.1700659 · DOI
- Leung, 2019, Emergence of carbapenem-resistant Acinetobacter baumannii ST195 harboring blaOxa-23 isolated from bacteremia in Hong Kong, Microb. Drug Resist., 25, 1199, 10.1089/mdr.2018.0433 · doi:10.1089/mdr.2018.0433
- Cheng, 2018, Control of multidrug-resistant Acinetobacter baumannii in Hong Kong: Role of environmental surveillance in communal areas after a hospital outbreak, Am. J. Infect. Control, 46, 60, 10.1016/j.ajic.2017.07.010 · DOI
- Gaddy, 2009, The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells, Infect. Immun., 77, 3150, 10.1128/IAI.00096-09 · DOI · Paper page
- Yang, C.H., Su, P.W., Moi, S.H., and Chuang, L.Y. (2019). Biofilm formation in Acinetobacter baumannii: Genotype-phenotype correlation. Molecules, 24. · DOI · Paper page
- Webb, 2006, Enhanced biofilm formation and increased resistance to antimicrobial agents and bacterial invasion are caused by synergistic interactions in multispecies biofilms, Appl. Environ. Microbiol., 72, 3916, 10.1128/AEM.03022-05 · DOI · Paper page
- Loehfelm, 2008, Identification and characterization of an Acinetobacter baumannii biofilm-associated protein, J. Bacteriol., 190, 1036, 10.1128/JB.01416-07 · DOI · Paper page
- Tomaras, 2003, Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: Involvement of a novel chaperone-usher pili assembly system, Microbiology, 149, 3473, 10.1099/mic.0.26541-0 · DOI · Paper page
- He, 2015, Biofilm formation caused by clinical Acinetobacter baumannii isolates is associated with overexpression of the adeFGH efflux pump, Antimicrob. Agents Chemother., 59, 4817, 10.1128/AAC.00877-15 · DOI · Paper page
- Peleg, 2008, Acinetobacter baumannii: Emergence of a successful pathogen, Clin. Microbiol. Rev., 21, 538, 10.1128/CMR.00058-07 · DOI · Paper page
- Visca, 2011, Acinetobacter infection–an emerging threat to human health, IUBMB Life, 63, 1048, 10.1002/iub.534 · DOI · Paper page
- Chen, 2014, Rapid identification of Acinetobacter baumannii, Acinetobacter nosocomialis and Acinetobacter pittii with a multiplex PCR assay, J. Med. Microbiol., 63, 1154, 10.1099/jmm.0.071712-0 · doi:10.1099/jmm.0.071712-0
- Bartual, 2005, Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii, J. Clin. Microbiol., 43, 4382, 10.1128/JCM.43.9.4382-4390.2005 · DOI · Paper page
- 2000, A Modified microtiter-plate test for quantification of staphylococcal biofilm formation, J. Microbiol. Methods, 40, 175, 10.1016/S0167-7012(00)00122-6 · DOI · Paper page
- Manchanda, 2010, Multidrug resistant Acinetobacter, J. Glob. Infect. Dis., 2, 291, 10.4103/0974-777X.68538 · DOI · Paper page
- Moskowitz, 2004, Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis, J. Clin. Microbiol., 42, 1915, 10.1128/JCM.42.5.1915-1922.2004 · DOI · Paper page
- Bogachev, M.I., Volkov, V.Y., Markelov, O.A., Trizna, E.Y., Baydamshina, D.R., Melnikov, V., Murtazina, R.R., Zelenikhin, P.V., Sharafutdinov, I.S., and Kayumov, A.R. (2018). Fast and simple tool for the quantification of biofilm-embedded cells sub-populations from fluorescent microscopic images. PLoS ONE, 13. · DOI
- Marques, 2015, Isolation of persister cells from biofilm and planktonic populations of Pseudomonas aeruginosa, Bio-Protocol, 5, e1590, 10.21769/BioProtoc.1590 · DOI
- Anghel, 2011, Pathogenic features and therapeutical implications of biofilm development ability in microbial strains isolated from rhinologic chronic infections, Farmacia, 59, 770
- Babapour, 2016, Biofilm formation in clinical isolates of nosocomial Acinetobacter baumannii and its relationship with multidrug resistance, Asian Pac. J. Trop. Biomed., 6, 528, 10.1016/j.apjtb.2016.04.006 · DOI
- Qi, 2016, Relationship between antibiotic resistance, biofilm formation, and biofilm-specific resistance in Acinetobacter baumannii, Front. Microbiol., 7, 483, 10.3389/fmicb.2016.00483 · DOI · Paper page
- Marti, 2008, Biofilm formation in Acinetobacter baumannii: Associated features and clinical implications, Clin. Microbiol. Infect., 14, 276, 10.1111/j.1469-0691.2007.01916.x · DOI · Paper page
- Wang, 2018, Biofilm formation is not associated with worse outcome in Acinetobacter baumannii bacteraemic pneumonia, Sci. Rep., 8, 7289, 10.1038/s41598-018-25661-9 · DOI
- Perez, 2015, Acinetobacter baumannii displays inverse relationship between meropenem resistance and biofilm production, J. Chemother., 27, 13, 10.1179/1973947813Y.0000000159 · doi:10.1179/1973947813y.0000000159
- Brossard, 2012, The Acinetobacter baumannii biofilm-associated protein plays a role in adherence to human epithelial cells, Infect. Immun., 80, 228, 10.1128/IAI.05913-11 · DOI · Paper page
- Bagge, 2004, Dynamics and spatial distribution of β-lactamase expression in Pseudomonas aeruginosa biofilms, Antimicrob. Agents. Chemother., 48, 1168, 10.1128/AAC.48.4.1168-1174.2004 · DOI · Paper page
- Pamp, 2008, Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes, Mol. Microbiol., 68, 223, 10.1111/j.1365-2958.2008.06152.x · DOI · Paper page
- Bernier, S.P., Lebeaux, D., DeFrancesco, A.S., Valomon, A., Soubigou, G., Coppée, J.Y., Ghigo, J.M., and Beloin, C. (2013). Starvation, together with the sos response, mediates high biofilm-specific tolerance to the fluoroquinolone ofloxacin. PLoS Genet., 9. · DOI · Paper page
- Page, 2016, Toxin-antitoxin systems in bacterial growth arrest and persistence, Nat. Chem. Biol., 12, 208, 10.1038/nchembio.2044 · DOI · Paper page
Cited by
Biofilm Resilience: Molecular Mechanisms Driving Antibiotic Resistance in Clinical Contexts
Almatroudi, A. (2025) · Biology · doi:10.3390/biology14020165 · Cited by 303
Metadata
- Authors
- Shenkutie, A. M., Yao, M. Z., Siu, G. K.-H., Wong, B. K. C., & Leung, P. H.-M.
- Venue
- Antibiotics
- Publisher
- MDPI AG
- Published
- 2020-11-17
- Volume
- 9
- Issue
- 11
- Pages
- 817
- ISSN
- 2079-6382
- Cited by
- 100
- References
- 2
- Language
- en
- Funders
- The Hong Kong PhD Fellowship Scheme (PH16-01625)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Biofilm-Induced Antibiotic Resistance in Clinical Acinetobacter baumannii Isolates. https://app.cochat.ai/papers/10.3390/antibiotics9110817
- The paper
- Shenkutie, A. M., Yao, M. Z., Siu, G. K.-H., Wong, B. K. C., & Leung, P. H.-M. (2020). Biofilm-Induced Antibiotic Resistance in Clinical Acinetobacter baumannii Isolates. Antibiotics. https://doi.org/10.3390/antibiotics9110817
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.